Testimony Tying Suicide, Pfizer Epilepsy Drug OK'd

Law360, New York (May 7, 2009, 12:00 AM EDT) -- The federal judge presiding over the multidistrict litigation alleging that Neurontin causes behavioral disturbances has rejected Pfizer Inc.'s bid to exclude expert testimony linking the epilepsy drug to suicide.

On Tuesday, Judge Patti Saris of the U.S. District Court for the District of Massachusetts issued a 96-page opinion, finding that the plaintiffs had proved the reliability of the expert testimony.

Pfizer asked the court to exclude the testimony of several witnesses, including the claims of a University of London neurologist that Pfizer ignored his recommendation more...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.